4582SymBio Pharmaceuticals Limited¥ --

SymBio Pharmaceuticals Limited

4582

TSE PrimePharmaceuticals

¥ -

View detailed cash flow statement data.

paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2026 Q2

Operating CF

-24.7B JPY

YoY +1.5%

Investing CF

-29.9M JPY

YoY -104.6%

Financing CF

5.6B JPY

YoY -67.0%

Free CF

-24.7B JPY

YoY +1.2%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

36.2億0

-45.8億

0000

1.4億

-7085万

-7192万

2021

16.1億

6.3億

-4713万

2022

6.8億

-3.8億

-1.9億

2023

7.1億

-396万

-34.2億

2024

36.2億

-7592万

-45.8億

2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

52.6億26.3億0-26.3億-52.6億

20212022202320242025

waterfall_chartCash Flow Bridge (FY2025 Annual)

Beginning / Ending

Increase

Decrease

60億40億20億0-20億

39.1億

Opening Cash

-45.8億

Operating CF

-7592万

Investing CF

36.2億

Financing CF

Other

28.8億

Closing Cash

Cash Flow Statement

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan